---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-053506"
form_type: "8-K"
ticker: "XAGE"
cik: "0001842939"
company_name: "Longevity Health Holdings, Inc."
filed_at: "2025-04-14T23:59:59+00:00"
generated_at: "2026-05-23T15:39:20.725424+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Longevity Health signs merger with 20/20 Biolabs; combined co. valued ~$99M

## Summary
- All-stock merger: 20/20 stockholders to own ~50.1% of combined co. (pre-concurrent financing).
- Combined co. FY2025 revenue forecast to double to ~$7-8M from ~$3-4M; ~$1M synergies expected.
- Post-closing: Jonathan Cohen (20/20 CEO) becomes CEO; Rajiv Shukla remains Chairman.
- Concurrent financing to raise min. $4M gross proceeds; also at-market offering for up to $2M common stock.
- Closing expected Q3 2025; subject to stockholder approvals, Nasdaq listing, and other conditions.

## SEC filing metadata
- accession: 0000950170-25-053506
- form_type: 8-K
- ticker: XAGE
- cik: 0001842939
- company_name: Longevity Health Holdings, Inc.
- filed_at: 2025-04-14T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 5.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842939/000095017025053506/0000950170-25-053506-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842939/000095017025053506/xage-20250411.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-053506
- JSON: https://secwatch.observer/filing/0000950170-25-053506.json
- Plain text: https://secwatch.observer/filing/0000950170-25-053506.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.